Results 221 to 230 of about 153,260 (300)

Impact of Hypothermic Temperature Control on Plasma and Soft Tissue Pharmacokinetics of Penicillin/Beta-Lactamase Inhibitor Combinations in Patients Resuscitated After Cardiac Arrest [PDF]

Alexandra-Maria Stommel, Peter Matzneller, Valentin al Jalali, Beatrix Wulkersdorfer, Edith Lackner, Matthias Müeller, Christoph Dorn, Michael Hölzer, Markus Zeitlinger   +8 more
openalex   +1 more source

Ampicillin sulbactam impacts serum potassium level comparable to piperacillin tazobactam. [PDF]

Sci Rep
Tashiro S, Tanaka R, Shiraiwa K, Hashimoto T, Tatsuta R, Hiramatsu K, Itoh H.   +6 more
europepmc   +1 more source

Isolation and structure of a .BETA.-lactamase inhibitor from Streptomyces.

, 1977
Kenji Maeda, Sakiko Takahashi, Masaji Sezaki, KATSUHARU IINUMA, HIROSHI NAGANAWA, Shinichi Kondo, Masaji Ohno, HAMAO UMEZAWA   +7 more
openalex   +2 more sources

Polyphenols as Potential β-Lactamase Inhibitors: An Integrated Computational and Experimental Study. [PDF]

Molecules
Mourabiti F, Jouga F, Calvo LG, Villarino RA, Zouheir Y, Soukri A, de Miguel T, El Khalfi B.   +7 more
europepmc   +1 more source

Activity of novel antibiotics against dual metallo-Beta-lactamase producing <i>Enterobacter hormaechei</i> clinical isolates. [PDF]

JAC Antimicrob Resist
Solar C, Diaz L, Soto K, Martínez JRW, Canales N, Bergman Y, Peters A, Araos R, García P, Tamma PD, Munita JM.   +10 more
europepmc   +1 more source

Insights into <i>Klebsiella pneumoniae</i> carbapenem resistance-a two-year retrospective study from a Romanian tertiary care hospital. [PDF]

Front Microbiol
Tălăpan D, Dan MO, Cireşă A, Rafila A.   +3 more
europepmc   +1 more source

The crystal structure of the carbapenemase OXA-24 in complex with tazobactam reveals evidences about the intereaction with beta-lactamase inhibitors and lysine carboxylation

, 2014
P.P. Power, E. Sauvage, R. Herman, Gabriel Gutkin, Moreno Galleni, P. Charlier, Frédéric Kerff   +6 more
openalex   +1 more source

In vitro activity of cefepime/zidebactam against sulbactam/durlobactam-susceptible and -resistant Acinetobacter baumannii clinical isolates. [PDF]

J Antimicrob Chemother
Tascini C, Bianco G, Bonomo RA, Gaibani P.   +3 more
europepmc   +1 more source

Real-World Data on Severe Cutaneous Adverse Reactions to Drugs. [PDF]

Pharmaceuticals (Basel)
Zyryanov S, Terehina E, Butranova O, Asetskaya I, Polivanov V, Yudin A.   +5 more
europepmc   +1 more source

<i>In vitro</i> evolution of durlobactam resistance in NDM-producing <i>Escherichia coli</i> due to a single mutation in <i>mrdA</i> encoding penicillin-binding protein 2. [PDF]

Antimicrob Agents Chemother
McElheny CL, Butcher EL, Kawai A, Shanks RMQ, Shields RK, Doi Y.   +5 more
europepmc   +1 more source